Interestingly, we found that the specific subset of myeloid cells c15 enriched during tumor progression, expressed high level of VEGFA, suggesting that the resistance mechanism to immunotherapy might be led by this specific subpopulation of myeloid cells and reverted by the neutralization on VEGFA with specific antibodies. The gene discussed is VEGFA; the disease is neoplasm.